Subscribe
ftc-istock-530746621-rivernorthphotography
RiverNorthPhotography / iStockphoto.com
11 April 2017Americas

Shire files motion to dismiss FTC allegations

Shire Viropharma has filed a motion to dismiss a complaint by the Federal Trade Commission (FTC), following competition allegations made against the pharmaceutical company.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
FTC to appeal Shire ViroPharma ‘abuse’ decision
12 April 2018   The US Federal Trade Commission is to appeal against a court’s decision to dismiss its competition complaint against Shire ViroPharma, a subsidiary of pharmaceutical company Shire.
Americas
FTC accuses Shire ViroPharma of antitrust violation
8 February 2017   The US Federal Trade Commission has filed a complaint against Shire ViroPharma, accusing the pharmaceutical company of violating antitrust laws.


Editor's picks

A step too far? Why Stewart’s approach is dividing opinion
Americas
A step too far? Why Stewart’s approach is dividing opinion
24 June 2025

Editor's picks

Americas
A step too far? Why Stewart’s approach is dividing opinion
24 June 2025
Europe
UPC confirms permanent injunction against Curio in 10x tech dispute
17 June 2025
Americas
LSPN: In-house ‘chess game’ is the same, but the rules have changed
9 May 2025
Americas
Life sciences leaders recognised at LSPN Awards USA 2025
8 May 2025
Americas
LSPN: Counsel grapple with AI’s impact on training and critical thinking
8 May 2025
Americas
LSPN: Using ‘the patentee’s friend’ in Section 112 claims
6 May 2025

More on this story

Americas
FTC to appeal Shire ViroPharma ‘abuse’ decision
12 April 2018   The US Federal Trade Commission is to appeal against a court’s decision to dismiss its competition complaint against Shire ViroPharma, a subsidiary of pharmaceutical company Shire.
Americas
FTC accuses Shire ViroPharma of antitrust violation
8 February 2017   The US Federal Trade Commission has filed a complaint against Shire ViroPharma, accusing the pharmaceutical company of violating antitrust laws.

More on this story

Americas
FTC to appeal Shire ViroPharma ‘abuse’ decision
12 April 2018   The US Federal Trade Commission is to appeal against a court’s decision to dismiss its competition complaint against Shire ViroPharma, a subsidiary of pharmaceutical company Shire.
Americas
FTC accuses Shire ViroPharma of antitrust violation
8 February 2017   The US Federal Trade Commission has filed a complaint against Shire ViroPharma, accusing the pharmaceutical company of violating antitrust laws.

More features

Bankruptcy judge approves $305m sale of genetics testing company
Sanofi successfully challenges rare disease patent in Europe
Bayer appoints new head of IP
WATCH: Policy direction—where are we now?
Broad Institute wins appeal to restore CRISPR patent in Europe
BMS faces fresh lawsuit over alleged cancer drug monopoly
WATCH: Synergy in science—navigating the landscape of pharmaceutical collaborations
Boies Schiller Flexner adds three-strong litigation team